Identification of metastatic papillary thyroid carcinoma in FNA specimens using thyroid peroxidase immunohistochemistry

被引:9
作者
Shield, P. W. [1 ,2 ]
Crouch, S. J. [3 ]
Papadimos, D. J. [1 ,3 ]
Walsh, M. D. [3 ]
机构
[1] Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld, Australia
[2] Sullivan Nicolaides Pathol, Cytol Dept, Brisbane, Qld, Australia
[3] Sullivan Nicolaides Pathol, Histopathol Dept, Brisbane, Qld, Australia
关键词
cytology; fine needle aspiration; immunohistochemistry; metastatic; thyroid papillary carcinoma; thyroid peroxidase; FINE-NEEDLE-ASPIRATION; TRANSCRIPTION FACTOR-I; LYMPH-NODE METASTASES; DIFFERENTIAL-DIAGNOSIS; THYROGLOBULIN; CANCER; CYTOLOGY; TUMORS; GALECTIN-3; PITFALL;
D O I
10.1111/cyt.12531
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
IntroductionWe evaluated immunohistochemical staining for thyroid peroxidase (TPO), a glycoprotein found in the apical plasma membrane of thyroid follicular cells, as a marker for metastatic PTC in FNA samples and compared results with thyroglobulin (Tg) and thyroid transcription factor 1 (TTF1) staining. MethodsCell block sections prepared from 100 FNA specimens were stained with a rabbit monoclonal antibody to TPO (EP159). The FNAs included 64 metastatic malignancies from non-thyroid primary sites, including 18 lung, and 36 cases of thyroid tumours (29 PTC, six cases of medullary thyroid carcinoma and one thyroid anaplastic carcinoma). Thyroid tumours were stained with TTF1 and Tg in addition to TPO. All cases of metastatic lung carcinoma also had TTF-1 staining results. ResultsTPO staining was negative in all non-thyroid malignancies. Ninety percent (26/29) of PTC were positive. All positive cases showed strong cytoplasmic staining, although 54% (14/26) showed positivity in less than half of the cells. By comparison, Tg staining of TPC cases was present in 62% and TTF-1 in 100%. In addition to showing higher sensitivity, interpretation of staining results with TPO was generally easier with than Tg. All metastatic lung adenocarcinomas were positive for TTF-1 and TPO negative. The six medullary cancers showed positivity in 17%, 0% and 83% with TPO, Tg and TTF-1, respectively. ConclusionsTPO (mAb EP159) may be a useful addition to immunohistochemical panels for FNA specimens where metastatic PTC is a consideration, particularly in cases where metastatic lung carcinoma features in the differential diagnosis. Ninety percent of metastatic papillary thyroid carcinomas in cell block specimens from lymph node aspirates were positive for thyroid peroxidase. This was more sensitive than thyroglobulin and more specific than TTF-1, which also stained all metastatic lung adenocarcinomas.
引用
收藏
页码:227 / 232
页数:6
相关论文
共 50 条
  • [31] Impact of the Reclassification of "Noninvasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma" to "Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features" on the Bethesda System for Reporting Thyroid Cytopathology
    Lau, Ryan P.
    Paulsen, John D.
    Brandler, Tamar C.
    Liu, Cheng Z.
    Simsir, Aylin
    Zhou, Fang
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2018, 149 (01) : 50 - 54
  • [32] Diagnostic Value of TROP-2 and CK19 Expression in Papillary Thyroid Carcinoma in Both Surgical and Cytological Specimens
    Abdou, Asmaa Gaber
    Shabaan, Mohammed
    Abdallha, Rania
    Nabil, Nehal
    CLINICAL PATHOLOGY, 2019, 12
  • [33] Barriers to the recognition of medullary thyroid carcinoma on FNA: Implications relevant to the new American Thyroid Association guidelines
    Dyhdalo, Kathryn S.
    Chute, Deborah J.
    CANCER CYTOPATHOLOGY, 2018, 126 (06) : 397 - 405
  • [34] Incidental Papillary Thyroid Carcinoma: Diagnostic Findings in a Series of 287 Carcinomas
    Pagni, Fabio
    Jaconi, Marta
    Delitala, Alberto
    Garancini, Mattia
    Maternini, Matteo
    Bono, Francesca
    Giani, Alessandro
    Smith, Andrew
    ENDOCRINE PATHOLOGY, 2014, 25 (03) : 288 - 296
  • [35] False-positive cytopathology results for papillary thyroid carcinoma: A trap for thyroid surgeons
    Yi, K. -I.
    Ahn, S.
    Park, D. Y.
    Lee, J. -C.
    Lee, B. -J.
    Wang, S. -G.
    Cha, W.
    CLINICAL OTOLARYNGOLOGY, 2017, 42 (06) : 1153 - 1160
  • [36] Risk factors of distant metastasis in the follicular variant of papillary thyroid carcinoma
    Li, Yan-Rong
    Chen, Szu-Tah
    Hseuh, Chuen
    Chao, Tzu-Chieh
    Ho, Tsung-Ying
    Lin, Jen-Der
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2016, 115 (08) : 665 - 671
  • [37] Fine-needle aspiration of metastatic papillary thyroid carcinoma found in the liver
    VandenBussche, Christopher J.
    Gocke, Christopher D.
    Li, Qing Kay
    DIAGNOSTIC CYTOPATHOLOGY, 2013, 41 (05) : 418 - 424
  • [38] Immunohistochemical diagnosis of papillary thyroid carcinoma
    Cheung, CC
    Ezzat, S
    Freeman, JL
    Rosen, IB
    Asa, SL
    MODERN PATHOLOGY, 2001, 14 (04) : 338 - 342
  • [39] THYROGLOBULIN AND THYROID PEROXIDASE AS THYROID-CELL MARKERS IN THE DIAGNOSIS OF THYROID-CARCINOMA
    DEMICCO, C
    RUF, J
    HENRY, JF
    CARAYON, P
    DIAGNOSTIC ONCOLOGY, 1991, 1 (03): : 190 - 193
  • [40] Variants of Papillary Thyroid Carcinoma: An Algorithmic Cytomorphology-Based Approach to Cytology Specimens
    Canberk, Sule
    Montezuma, Diana
    Ince, Umit
    Tastekin, Ebru
    Soares, Paula
    Bongiovanni, Massimo
    Schmitt, Fernando C.
    ACTA CYTOLOGICA, 2020, 64 (04) : 288 - 298